UHS Universal Health Services Inc. Class B

Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Universal Health Services Inc. (UHS) and Encourages Investors with Losses to Contact the Firm

Bragar Eagel & Squire, P.C. reminds investors that a class action lawsuit has been filed in the U.S. District Court for the Central District of California on behalf of all persons or entities who acquired Universal Health Services Inc. (NYSE:UHS) securities between February 26, 2015 and December 7, 2016 (the “Class Period”). Investors have until February 21, 2017 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

Universal Health owns and operates acute care hospitals, behavioral health centers, surgical hospitals, ambulatory surgery centers, and radiation oncology centers.

The Complaint alleges that throughout the Class Period, Defendants made false and/or misleading statements and/or failed to disclose that: (1) Universal Health admitted patients based on its own financial considerations and not upon the medical necessity of the patient; (2) Universal Health would keep patients admitted until their insurance payments ran out in order to ensure the maximum payment for its services; (3) as a result, Universal Health’s revenues from inpatient care relied on unsustainable practices; and (4) in turn, Universal Health lacked effective internal controls concerning its practices and policies of admitting patients. As a result, Universal Health’s public statements were materially false and misleading throughout the Class Period.

On December 7, 2016, BuzzFeed published the results of a yearlong investigation “based on interviews with 175 current and former UHS staff, including 18 executives who ran UHS hospitals; more than 120 additional interviews with patients, government investigators, and other experts; and a cache of internal documents.” According to the report, “[c]urrent and former employees from at least 10 UHS hospitals in nine states said they were under pressure to fill beds by almost any method – which sometimes meant exaggerating people’s symptoms or twisting their words to make them seem suicidal – and to hold them until their insurance payments ran out.” Following this news, Universal Health shares declined $15.01 per share, or over 11.8%, on December 7, 2016 to close at $111.36.

If you purchased or otherwise acquired Universal Health securities during the Class Period and suffered a loss or continue to hold shares purchased prior to the Class Period, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact J. Brandon Walker, Esq. by email at [email protected], or telephone at (212) 355-4648, or by filling out this contact form. There is no cost or obligation to you.

Bragar Eagel & Squire, P.C. is a New York-based law firm concentrating in commercial and securities litigation. For additional information concerning the Universal Health lawsuit, please go to www.bespc.com/uhs. For additional information about Bragar Eagel & Squire, P.C., please go to www.bespc.com.

EN
14/02/2017

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Universal Health Services Inc. Class B

Universal Health Services Inc: 1 director

A director at Universal Health Services Inc sold/sold after exercising options 35,000 shares at 176.818USD and the significance rating of the trade was 75/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the compan...

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vermilion Compass: Weekly Equity Strategy

Small Caps Outperform Despite "Hot" Inflation Reports In spite of last week's hotter-than-expected inflation reports (CPI and PPI), the S&P 500 remains above its 20-day MA, and, more notably, the Russell 2000 (IWM) outperformed relative to the SPX and QQQ, and ended the week at YTD weekly closing highs. Small-caps are supposed to fall and/or underperform if inflation is on the rise. When stocks do the opposite of what is expected of them, that is valuable information. The fact that small- and m...

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vermilion Compass: Weekly Equity Strategy

Monitoring Rising Treasury Yields & U.S. Dollar (DXY) The Fed wanting "greater confidence" that inflation is sustainably moving toward its 2% target signals a patient approach with respect to rate cuts, meaning a more restrictive policy than the market expected. This is disproportionately hitting small- and mid-caps which are more sensitive to higher interest rates. This suggests we could see further consolidation for small- and mid-caps, while large-cap indexes (S&P 500, Nasdaq 100, DJI) remai...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch